Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer — Proceedings from the 2026 Annual ONS Congress
Featuring perspectives from Dr Alexandra Drakaki, Ms Krisztina Emodi, Dr Terence Friedlander and Ms Margarita Huober, moderated by Dr Friedlander, including the following topics:
- Introduction: Basic Biology of Nonmetastatic Urothelial Bladder Cancer (UBC) (0:00)
- Systemic Therapy for Cisplatin-Eligible Patients with Muscle-Invasive Bladder Cancer (MIBC) (13:35)
- Evolving Approach to Systemic Therapy for Cisplatin-Ineligible Patients with MIBC (37:13)
- Immune Checkpoint Inhibitors in Non-Muscle-Invasive Bladder Cancer (58:55)
- Novel Intravesical Therapies for Nonmetastatic UBC (1:10:20)
